Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

AMPHOTERICIN B

All injection strengths: general benefit

Other products in the same Health Canada class (J02A) — coverage varies; not interchangeable

  • Fluconazole (Diflucan P.O.S.): general benefit, Limited Use 528, Not a benefit
  • Itraconazole (Sporanox): general benefit, Limited Use 570, Not a benefit
  • Ketoconazole (Nizoral): general benefit, Not a benefit
  • Voriconazole (Vfend): limited Use 399
  • Caspofungin (Cancidas): not a benefit
  • Micafungin (Mycamine): not a benefit

1 more in the class list below

Fungizone · DIN 00029149 · · injection Pd-50mg Pk

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Fungizone · DIN 00029149 Manufacturer: Cheplapharm Arzneimittel GmbH; listing date 1996-10-01 Health Canada: Marketed since 2020-01-02 · brand FUNGIZONE · ATC J02AA01 AMPHOTERICIN B · form Powder for solution · route Intravenous · ingredients AMPHOTERICIN B 50 MG/VIAL · company Cheplapharm arzneimittel gmbh · schedule Prescription
Check this DIN again · Health Canada product record

Fungizone: Formulary list price $104.0511/unit (unit not stated in source; not the patient's cost)

Ministry pays: $104.0511 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=933 · Verify on the e-Formulary ↗ (DIN 00029149)

Source record
DIN 00029149: Fungizone Raw flags: sec3=Y Item: 081204001; group id 6; item number 0008; lccId None; manufacturer id CHE Source form: Inj Pd-50mg Pk; strength: None Recorded listing: General benefit Source prices (unrounded): $104.0511; ministry $104.0511 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00029149 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=933
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (08:12:04 Antifungals) and how they are covered

Matched class: 08:12:04 Antifungals

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): FLUCONAZOLE, ITRACONAZOLE, KETOCONAZOLE, NYSTATIN, TERBINAFINE HCL 08:12:04 Antifungals

FLUCONAZOLE

· 17 products · Limited Use, codes 528 (1), Listed, not a benefit (2), General benefit (14) · strengths: 10mg/mL, 50mg, 100mg · O/L, Tab

ITRACONAZOLE

· 5 products · General benefit (2), Listed, not a benefit (1), Limited Use, codes 570 (2) · strengths: 100mg, 10mg/mL · Cap, Oral Sol

KETOCONAZOLE

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 200mg · Tab

VORICONAZOLE

· 6 products · Limited Use, codes 399 · strengths: 50mg, 200mg · Tab

CASPOFUNGIN ACETATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mg/Vial · Inj-Vial Pk

MICAFUNGIN SODIUM

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mg/Vial, 100mg/Vial · Inj Pd-10mL Vial Pk

POSACONAZOLE

· 7 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 100mg, 40mg/mL · DR Tab, O/L

NYSTATIN

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 100000U/mL · O/L

TERBINAFINE HCL

· 8 products · Listed, not a benefit (1), General benefit (7) · strengths: 250mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:04
Full class listing Related classes: 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE FUNGIZONE (amphotericin B) is specifically intended for the treatment of disseminated mycotic infections, including coccidioidomycosis; cryptococcosis (torulosis); disseminated candidiasis, histoplasmosis, South American leishmaniasis, North and South American blastomycosis; mucormycosis (phycomycosis) caused by species of the genera Mucor, Rhizopus, Absidia, Entomophthora, and Basidiobolus, sporotrichosis (Sporotrichum schenckii), and aspergillosis (Aspergillus fumigatus). Other Clinical Uses Limited studies have shown that amphotericin B powder for injection may be useful when administered by routes other than intravenous for the treatment of certain types of fungal infections. 4 1. Administration by Bladder Irrigation The effective use of amphotericin B for fungal infections of the bladder has been reported in the literature. The basic method used for bladder irrigation is as follows: 15 mg FUNGIZONE powder is dissolved in 100 to 400 mL of sterile water and injected via catheter after complete emptying of the bladder. The… https://pdf.hres.ca/dpd_pm/00054740.PDF PM date: December 12, 2019 Source product: FUNGIZONE; DIN 00029149; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.